|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/48 | |
| A61K 38/36 | |||
| A61K 45/06 | |||
| A61K 9/22 | |||
| A61P 3/10 |
| (11) | Number of the document | 2437732 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10784223.9 |
| Date of filing the European patent application | 2010-06-07 | |
| (97) | Date of publication of the European application | 2012-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/037605 |
| Date | 2010-06-07 |
| (87) | Number | WO 2010/141938 |
| Date | 2010-12-09 |
| (30) | Number | Date | Country code |
| 217906 P | 2009-06-05 | US |
| (72) |
CINCOTTA, Anthony, H., US
|
| (73) |
VeroScience LLC,
1334 Main Road, Tiverton RI 02878,
US
|
| (54) | COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |
| COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |